Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Currently there is no cure for multiple sclerosis (MS). Immunosuppressive and immunomodulatory treatments including glucocorticoids (GC) are used to treat acute attacks of MS and slow relapses. However, no adequate biomarkers exist to show treatment efficacy and/or development of treatment resistance. Therefore, the goal of this project is to identify biomarkers to monitor whether immunomodulatory treatments in MS are effective and/or whether patients develop treatment resistance. We will study glucocorticoid (GC) treatment of mice with experimental autoimmune encephalomyelitis (EAE) as a generally accepted model of MS. Combining immunological studies with proteomics methods we expect to discover proteins (biomarkers) that indicate when the GC treatment is effective and furthermore provide us information on the mechanisms of GC resistance.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Research Centers in Minority Institutions Award (G12)
Project #
5G12RR013646-12
Application #
8357130
Study Section
Special Emphasis Panel (ZRR1-RI-B (01))
Project Start
2011-07-01
Project End
2012-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
12
Fiscal Year
2011
Total Cost
$167,806
Indirect Cost

  Institution

Name
University of Texas Health Science Center San Antonio
Department
Type
Other Domestic Higher Education
DUNS #
800189185
City
San Antonio
State
TX
Country
United States
Zip Code
78249

  Publications

Ye, Ruquan; Dong, Juncai; Wang, Luqing et al. (2018) Manganese deception on graphene and implications in catalysis. Carbon N Y 132:623-631
Everett, James; Collingwood, Joanna F; Tjendana-Tjhin, Vindy et al. (2018) Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects. Nanoscale 10:11782-11796
Ortega, Eduardo; Ponce, Arturo; Santiago, Ulises et al. (2017) Structural damage reduction in protected gold clusters by electron diffraction methods. Adv Struct Chem Imaging 2:12
Rodriguez, Roberto A; Chen, Liao Y; Plascencia-Villa, Germán et al. (2017) Elongation affinity, activation barrier, and stability of A?42 oligomers/fibrils in physiological saline. Biochem Biophys Res Commun 487:444-449
Mimun, L Christopher; Ajithkumar, G; Rightsell, Chris et al. (2017) Synthesis and characterization of Na(Gd0.5Lu0.5)F4: Nd3+,a core-shell free multifunctional contrast agent. J Alloys Compd 695:280-285
Raphael, Itay; Webb, Johanna; Gomez-Rivera, Francisco et al. (2017) Serum Neuroinflammatory Disease-Induced Central Nervous System Proteins Predict Clinical Onset of Experimental Autoimmune Encephalomyelitis. Front Immunol 8:812
Srinivasan, Anand; Torres, Nelson S; Leung, Kai P et al. (2017) nBioChip, a Lab-on-a-Chip Platform of Mono- and Polymicrobial Biofilms for High-Throughput Downstream Applications. mSphere 2:
Rozinek, Sarah C; Thomas, Robert J; Brancaleon, Lorenzo (2016) Biophysical characterization of the interaction of human albumin with an anionic porphyrin. Biochem Biophys Rep 7:295-302
Plascencia-Villa, Germán; Ponce, Arturo; Collingwood, Joanna F et al. (2016) High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer's disease. Sci Rep 6:24873
Mendoza-Cruz, Rubén; Bazán-Díaz, Lourdes; Velázquez-Salazar, J Jesús et al. (2016) Helical Growth of Ultrathin Gold-Copper Nanowires. Nano Lett 16:1568-73

Showing the most recent 10 out of 181 publications